For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Moderna’s mRNA flu shot outperforms existing vaccines in Phase 3 trial, showing over 26% greater efficacy—paving the way for ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

Health and Human Services Secretary Robert F. Kennedy Jr. believes his opinion is “irrelevant” — but he has some advice for ...

Karnataka Chief Minister Siddaramaiah has expressed serious concern after more than 20 people reportedly died due to heart attacks in just one month in Hassan district. The sudden rise in such deaths ...

Karnataka: The state government said that a committee of experts has been set up to probe the deaths, and has been instructed ...

The analysis by the Royal College of Paediatrics and Child Health suggests the main barriers to access are factors like ...

Their insurance didn't cover the immunizations for their children, and the cost of the vaccine was more than five times what ...